Preferred Label : protease inhibitors;

MeSH definition : Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES).;

MeSH synonym : endopeptidase inhibitors; protease inhibitor; peptide hydrolase inhibitors; hydrolase inhibitors, peptide; peptide peptidohydrolase inhibitors; inhibitors, peptide peptidohydrolase; peptidohydrolase inhibitors, peptide; antagonists, protease; antiproteases; inhibitors, peptidase; inhibitor, protease; inhibitors, endopeptidase; inhibitors, protease; peptidase inhibitors; protease antagonists; inhibitors, peptide hydrolase; Antiprotease; Endopeptidase Inhibitor; Inhibitor, Endopeptidase; Peptidase Inhibitor; Inhibitor, Peptidase; Peptide Hydrolase Inhibitor; Hydrolase Inhibitor, Peptide; Inhibitor, Peptide Hydrolase; Protease Antagonist; Antagonist, Protease; Peptide Peptidohydrolase Inhibitor; Inhibitor, Peptide Peptidohydrolase; Peptidohydrolase Inhibitor, Peptide;

MeSH annotation : PROTEASE INHIBITORY PROTEINS, SECRETORY is also available; DF: PROTEASE INHIB; PROTEASE INHIBITORY PROTEINS, SECRETORY is also available;

Wikipedia link : https://en.wikipedia.org/wiki/Protease inhibitors;

Is substance : O;

action pharmacologique : O;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES).

https://pharmacomedicale.org/medicaments/par-specialites/item/antiviraux-utilises-dans-les-hepatites-virales
2016
false
false
false
France
French
drug information
protease inhibitors
antiviral agents
nucleic acid synthesis inhibitors
interferon-alpha
Pegylated Interferon Alfa
hepatitis B
hepatitis C
viral hepatitis
hepatitis, viral, human
antiviral agents
hepatitis
viral hepatitis, nos
hepatitis

---
http://www.infectiologie.com/UserFiles/File/medias/Recos/2013-position-societes-savantes-IPantiVHC_et_coinfection.pdf
2013
false
true
true
false
false
France
French
HIV
hepacivirus
protease inhibitors
coinfection
coinfection
liver cirrhosis
coinfection
Chronic inflammation (morphologic abnormality)
hiv infections
hepatitis C
antiretroviral therapy, highly active
HIV
withholding treatment
drug resistance
antiretroviral therapy, highly active
anemia
exanthema
drug interactions
patient education as topic
patient compliance
patient care management
ribavirin
Nucleoside Reverse Transcriptase Inhibitor
anti-retroviral agents
drug substitution
HIV-1
guidelines for drug use

---
Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.